BPA for galafold
Active Awarded Last action
- Contract number
- 36E79727A0003
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 4% complete
- IDV ceiling
- $8,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center established a Blanket Purchase Agreement with Amicus Therapeutics US, LLC on October 21, 2026, with an $8 million ceiling and ultimate completion date of October 20, 2027, for supply of Galafold (migalastat) 123 mg capsules against the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
Place of performance is Philadelphia, Pennsylvania, or at Veterans Affairs facility locations nationwide. The BPA procures FDA-approved enzyme replacement therapy for Fabry disease treatment, supplied directly to the Department of Veterans Affairs. All ordering activity concentrates within the Veterans Health Administration, with Veterans Integrated Service Network 5 (Mid-Atlantic region) and VISN 7 among the highest-volume operational customers. Representative delivery orders include a $22.8 thousand call from VISN 5 on September 29, 2026, for Galafold capsules; a $68.5 thousand emergency pharmacy order from VISN 9 on August 24, 2026; and a $228.4 thousand order from VISN 7 on February 23, 2026. Delivery orders typically carry short performance windows measured in days to weeks, consistent with urgent pharmaceutical procurement patterns, and many are designated as emergency pharmacy purchases. All orders are firm fixed-price with no set-aside applied.
Quick answers
Who was awarded contract 36E79727A0003?
36E79727A0003 was awarded to Amicus Therapeutics US, LLC by National Acquisition Center (Headquarters) on October 21, 2026.
How much is contract 36E79727A0003 worth?
36E79727A0003's own ceiling is $8,000,000.
Who can order from contract 36E79727A0003?
36E79727A0003 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79727A0003 under another contract?
Yes. 36E79727A0003 is a blanket purchase agreement under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79727A0003 competed?
The extent of competition for 36E79727A0003 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV